canrenone has been researched along with digoxin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wachter, C; Wood, WG | 1 |
| Abshagen, U; Kuhlmann, J; Rennekamp, H | 1 |
| Foukaridis, GN | 1 |
| de Mendonça, M; Devynck, MA; Garay, R; Grichois, ML; Meyer, P; Pernollet, MG; Trouillet-Thormann, B; Wauquier, I | 1 |
| Gadsden, RH; Pleasants, RA; Porter, RS; Williams, DM | 1 |
| De Mendonca, M; Devynck, MA; Garay, R; Grichois, ML; Meyer, P; Pernollet, MG; Thorman, B | 1 |
| Bianchi, G; Duzzi, L; Ferrandi, M; Ferrari, P; Minotti, E | 1 |
| Eber, B; Emmanuilidis, K; Müller, C; Steimer, W | 1 |
| Eber, B; Müller, C; Steimer, W | 1 |
| Dasgupta, A; Datta, P; Saffer, H; Wells, A | 1 |
| Balzan, S; Bellitto, L; Biver, P; Ghione, S; Montali, U; Nicolini, G | 1 |
| Dasgupta, A; Datta, P | 1 |
| Dasgupta, A; Datta, P; Kang, E | 1 |
| Dasgupta, A; Tso, G; Wells, A | 1 |
| Armbruster, D; Cooper, KC; Dasgupta, A; DeFrance, A; Petty, D | 1 |
| Dasgupta, A; Johnson, MJ | 1 |
| Dasgupta, A; Johnson, MJ; Sengupta, TK | 1 |
17 other study(ies) available for canrenone and digoxin
| Article | Year |
|---|---|
A critical appraisal of a further three new commercial digoxin radioimmunoassay kits with reference to cross-reacting substances.
Topics: Blood Proteins; Canrenone; Cross Reactions; Digitoxin; Digoxin; Evaluation Studies as Topic; Furosemide; Humans; Radioimmunoassay; Reagent Kits, Diagnostic; Spironolactone | 1979 |
Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.
Topics: Administration, Oral; Adult; Bile; Canrenoic Acid; Canrenone; Digoxin; Feces; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Spironolactone; Tritium | 1976 |
Influence of spironolactone and its metabolite canrenone on serum digoxin assays.
Topics: Canrenone; Cross Reactions; Digoxin; Half-Life; Humans; Iodine Radioisotopes; Pregnadienes; Radioimmunoassay; Spironolactone | 1990 |
Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present.
Topics: Animals; Antihypertensive Agents; Blood Proteins; Canrenone; Cardenolides; Digoxin; Erythrocytes; Hypertension; Ion Channels; Male; Potassium; Pregnadienes; Rats; Rats, Inbred Strains; Saponins; Sodium; Sodium-Potassium-Exchanging ATPase | 1988 |
Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays.
Topics: Adult; Canrenone; Cross Reactions; Digoxin; Humans; Immunoassay; Immunoenzyme Techniques; Male; Radioimmunoassay; Spironolactone | 1989 |
Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
Topics: Animals; Antihypertensive Agents; Blood Volume; Canrenone; Cardenolides; Digoxin; Erythrocytes; Hypertension, Renal; Male; Ouabain; Rats; Rats, Wistar; Saponins; Sodium; Sodium-Potassium-Exchanging ATPase | 1985 |
Effect of canrenone and hydrochlorothiazide on the development of hypertension in rat models of genetic hypertension.
Topics: Animals; Biological Factors; Blood Pressure; Canrenone; Cardenolides; Digoxin; Disease Models, Animal; Hydrochlorothiazide; Hypertension; Rats; Rats, Inbred SHR; Saponins; Sodium-Potassium-Exchanging ATPase; Species Specificity | 1993 |
Intoxication due to negative canrenone interference in digoxin drug monitoring.
Topics: Aged; Canrenone; Digoxin; Drug Interactions; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Fatal Outcome; Humans; Male; Medication Errors; Multiple Organ Failure; Sepsis; Spironolactone | 1999 |
Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
Topics: Anti-Arrhythmia Agents; Canrenone; Chromatography, High Pressure Liquid; Cross Reactions; Digoxin; Diuretics; Drug Interactions; False Negative Reactions; Humans; Immunoenzyme Techniques; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Prodrugs; Reagent Kits, Diagnostic; Spironolactone | 2002 |
Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin.
Topics: Canrenoic Acid; Canrenone; Cardiotonic Agents; Digoxin; Drug Interactions; Fluorescence Polarization Immunoassay; Humans; Luminescent Measurements; Mineralocorticoid Receptor Antagonists; Reproducibility of Results; Spironolactone | 2002 |
Effect of canrenone on the digitalis site of Na+/K(+)-ATPase in human placental membranes and in erythrocytes.
Topics: Binding Sites; Binding, Competitive; Canrenone; Cardenolides; Cell Membrane; Digoxin; Erythrocytes; Fetal Blood; Humans; In Vitro Techniques; Mineralocorticoid Receptor Antagonists; Placenta; Radioligand Assay; Rubidium Radioisotopes; Saponins; Sodium-Potassium-Exchanging ATPase | 2003 |
A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is free from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Canrenoic Acid; Canrenone; Cardiotonic Agents; Cross Reactions; Digoxin; Drug Interactions; Fluorescence Polarization Immunoassay; Humans; Spironolactone | 2003 |
A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Artifacts; Canrenone; Cross Reactions; Digoxin; Enzyme-Linked Immunosorbent Assay; Fluorescence Polarization Immunoassay; Humans; Luminescent Measurements; Nephelometry and Turbidimetry; Reagent Kits, Diagnostic; Sensitivity and Specificity; Spironolactone | 2006 |
Effect of spironolactone, potassium canrenoate and their common metabolite canrenone on serum digoxin measurement by digoxin III, a new digoxin immunoassay.
Topics: Canrenoic Acid; Canrenone; Cross Reactions; Digoxin; Drug Interactions; Humans; Immunoassay; Mineralocorticoid Receptor Antagonists; Spironolactone | 2008 |
Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
Topics: Anti-Arrhythmia Agents; Canrenoic Acid; Canrenone; Chemistry, Clinical; Cross Reactions; Digoxin; Immunoassay; Mineralocorticoid Receptor Antagonists; Spironolactone | 2011 |
Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on Dimension Vista Digoxin Assay.
Topics: Biological Assay; Canrenoic Acid; Canrenone; Cardiotonic Agents; Chemistry, Clinical; Cross Reactions; Digoxin; Drug Interactions; Drug Monitoring; Humans; Immunoassay; Mineralocorticoid Receptor Antagonists; Osmolar Concentration; Reagent Kits, Diagnostic; Spironolactone | 2010 |
Clinically insignificant negative interferences of spironolactone, potassium canrenoate, and their common metabolite canrenone in new dimension vista LOCI digoxin immunoassay.
Topics: Canrenoic Acid; Canrenone; Digoxin; Humans; Immunoassay; Luminescent Measurements; Models, Molecular; Spironolactone | 2012 |